Development of a High Performance Clinical Cardiac SPECT/TCT System

描述（由申请人提供）：由于冠状动脉疾病（CAD）的患病率和SPECT用于评价冠状动脉疾病的成本效益，心脏SPECT程序占美国每年进行的1800万次核成像的近60%。然而，大多数用于心脏研究的SPECT系统尚未针对心脏成像进行优化。因此，该技术的应用范围和诊断准确性几十年来没有发生重大变化。迫切需要开发改进的心脏SPECT系统和技术，以满足临床和研究应用的现有和未来需求。为了满足这一需求，我们开发了一种新的平台- C-SPECT-用于心脏SPECT成像。它基于使用大面积轮廓探测器进行有效检测和多功能准直器系统从放置心脏的小体积进行有效采样。我们的设计有许多独特的规定，以优化大多数患者的成像，并将使自适应SPECT首次临床实用。它还包括一个集成的具有成本效益的TCT，为定量SPECT成像提供高质量的衰减图。我们的长期目标是帮助临床心脏SPECT实现其定量成像潜力。我们的方法是通过优化仪器来提高性能并扩展SPECT的临床功能。在本计画中，我们的目标是开发第一台实验室原型，C-SPECT-I，以实现其上级性能和多功能性。我们提议建立由Rush和Penn两个ECT小组组成的生物工程研究合作伙伴关系，以完成设计并构建原型，为未来转化为临床原型铺平道路。宾夕法尼亚大学的研究小组将带来他们在PET探测器、SPECT准直器和图像重建方面的专业知识，以补充拉什的系统设计。这是一项学术研究合作，旨在将PET、SPECT和CT技术的硬件和软件专业知识联合收割机结合起来。我们的合作伙伴关系是在一个很好的位置，采取这个项目的基础上，两个集团的跟踪记录在开发ECT系统。我们预计，C-SPECT-I将有更多的通用性和更高的（2- 2.5倍）的几何效率比传统的系统在相同的系统分辨率。最近，新的分辨率恢复重建（RRR）技术已被认为在几个新的心脏SPECT系统中，有效效率提高了许多倍（3- 9倍），而不影响诊断质量。我们将在C-SPECT-I中实现和优化这些软件处理技术的使用。通过优化的硬件和先进的软件，C-SPECT-I可以在相同的成像质量下，为心脏SPECT成像提供前所未有的有效效率。此外，由于快速和动态成像所需的图像质量降低，相对于现有系统，在C-SPECT-I中可以实现一个数量级的更高灵敏度或速度的增益。我们相信，随着性能、多功能性和功能性的潜在改进，C-SPECT平台将有助于开辟新的领域，提高质量，降低患者护理成本。

DESCRIPTION (provided by applicant): Because the prevalence of coronary artery disease (CAD) and SPECT 's cost-effectiveness for evaluation of coronary artery disease, cardiac SPECT procedures account for nearly 60% of the 18 millions nuclear imaging performed yearly in the US. However, most SPECT systems used for cardiac studies are not yet optimized for cardiac imaging. As a result, the scope of applications and diagnostic accuracy of the technique have not changed significantly for decades. There is an urgent need to develop improved cardiac SPECT systems and techniques to meet the existing and future demands for clinical and research applications. To address this need, we have developed a new platform - C-SPECT- for cardiac SPECT imaging. It is based on using a large-area contoured detector for efficient detection and a versatile collimator system for effective sampling from a small volume, in which the heart is placed. Our design has many unique provisions to optimize imaging for the majority of patients, and will make adaptive SPECT clinically practical for the first time. It also includes an integrated cost-effective TCT to provide quality attenuation maps for quantitative SPECT imaging. Our long-term goal is to help clinical cardiac SPECT to realize its quantitative imaging potential. Our approach is to improve the performance and expand the clinical functionality of SPECT through optimized instrumentation. In this project, our objective is to develop the first lab-prototype, C-SPECT-I, to realize its superior performance and versatility. We propose this Bioengineering Research Partnership, formed by the two ECT groups of Rush and Penn, to finalize the design and construct the prototype to pave the way for its future conversion to a clinical prototype. The group at Penn will bring their expertise in PET detectors, SPECT collimators, and image reconstruction to complement Rush's system design. This is an academic research collaboration formed to combine hardware and software expertise in PET, SPECT and CT technologies. Our partnership is in an excellent position to take on this project based on both groups' track records in developing ECT systems. We anticipate that the C-SPECT-I will have far more versatility and higher (2-2.5X) geometric efficiency than that of conventional systems at the same system resolution. Recently, the new resolution recovery reconstruction (RRR) techniques have been credited with many folds (3-9X) of increase in effective efficiency without compromising diagnostic quality in several new cardiac SPECT systems. We will implement and optimize the use of these software processing techniques in C-SPECT-I. With optimized hardware and advanced software, the C-SPECT-I could have an unprecedented effective efficiency for cardiac SPECT imaging for the same imaging quality. In addition, with reduced image quality required for fast and dynamic imaging, a gain of an order of magnitude higher sensitivity or speed could be achieved in C-SPECT-I relative to existing systems. We believe that with the potential improvements in performance, versatility and functionality, C-SPECT platform will help break new grounds and lead to improved quality and reduced cost of patient care.